VeriMompeg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment for this specific PEG-6 sesqui(benzotriazolyl t‑butyl hydroxyphenylpropionate) was identified in available regulatory sources. There are no published reproductive or developmental toxicity data specific to this ingredient in PubMed; by default and given its PEGylated UV‑absorber structure the concern is low but dermal exposure is expected to be low but measurable (CosIng / ECHA registration information typically indicate topical use/low dermal absorption for large PEG‑conjugates). Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
Related ingredients
Frequently asked questions
- peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment for this specific PEG-6 sesqui(benzotriazolyl t‑butyl hydroxyphenylpropionate) was identified in available regulatory sources. There are no published reproductive or developmental toxicity data specific to this ingredient in PubMed; by default and given its PEGylated UV‑absorber structure the concern is low but dermal exposure is expected to be low but measurable (CosIng / ECHA registration information typically indicate topical use/low dermal absorption for large PEG‑conjugates). Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
- peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) emzirirken güvenli mi?
- No data identified showing reproductive or lactation toxicity or transfer in breast milk for this ingredient. Mechanistic or animal evidence of transfer into milk was not found; expected systemic exposure from topical cosmetic use is low but measurable, so marginal potential for maternal systemic exposure exists. Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
- peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) bebek cildi için güvenli mi?
- No infant‑specific toxicity or developmental data were identified. Because the ingredient is a PEGylated benzotriazole UV‑absorber (moderate molecular size) and topical absorption in infants is typically higher than in adults, exposure score is increased by +1 for baby skin; however no evidence was found indicating intrinsic reproductive/developmental hazard. Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed, EWG.
- VeriMom peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) nasıl puanlıyor?
- VeriMom peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate)'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.